3 results match your criteria: "USA. Electronic address: jxiao@macrohardinstitute.org.[Affiliation]"
Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial.
Complement Ther Med
September 2022
The Macrohard Institute of Health, 231 North Ave, Battle Creek, MI 49017, USA. Electronic address:
Diarrhea predominant irritable bowel syndrome (IBS) is a highly relapsing gastrointestinal disorder decreasing the quality of life. Existing studies indicated that the therapeutic effects maintained for a period of time after the treatments were discontinued (post-treatment therapeutic effects or PTTE). In this study, we aim to assess the PTTE of tongxie.
View Article and Find Full Text PDF8-hydroxypinoresinol-4-O-β-D-glucoside from Valeriana officinalis L. Is a Novel Kv1.5 Channel Blocker.
J Ethnopharmacol
August 2021
The Macrohard Institute of Health, 231 North Ave, Battle Creek, MI, 49017, USA; The American Academy of Tradition Chinese Medicine Inc., 1925 W County Rd B2, Roseville, MN, 55113, USA. Electronic address:
Ethnopharmacology Relevance: In folkloric medicine of many cultures, one of the medical uses of Valeriana officinalis Linn is to treat heart-related disease. Recently, it was shown that the ethanol extracts from V. officinalis could effectively prevent auricular fibrillation, and 8-hydroxypinoresinol-4-O-β-D-glucoside (HPG) from the extracts is one of the two active compounds showing antiarrhythmia activities.
View Article and Find Full Text PDFAre personalized tongxie formula based on diagnostic analyses more effective in reducing IBS symptoms?-A randomized controlled trial.
Complement Ther Med
October 2018
The Macrohard Institute of Health. 231 North Ave. Battle Creek, MI 49017, USA. Electronic address:
Article Synopsis
- The study aimed to assess the effectiveness and safety of personalized tongxie formulas for treating IBS while minimizing type II errors.
- Patients were assigned to three groups (tongxie, placebo, pinaverium) and evaluated over 4 weeks for improvements in abdominal pain and stool consistency.
- Results showed that more patients experienced improved stool consistency and reduced stool frequency than pain relief, highlighting the importance of personalization in treatment for various IBS subtypes.